1. Home
  2. Stock quotes
  3. Stock Tarsus Pharmaceuticals
Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals TARS

$ 64.59 0.12%

Annual report 2025
added 02-23-2026

report update icon

Country

 usaUSA

IPO year

 2020

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 41.8 M

Market Cap[1]

 $ 2.7 B

EBITDA (LTM)

 $ -87.3 M

P/E (LTM)

 -31.78

P/S (LTM)

 7.75

EPS (LTM)

 -2.03

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Altimmune Altimmune
ALT
 		$ 3.47 3.89 % $ 306 M Nasdaq Global Market usaUSA
I-Mab I-Mab
IMAB
 		- - $ 866 M Nasdaq Global Select Market chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
 		- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
 		- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
 		$ 219.83 -0.92 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
 		- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
 		- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
Acasti Pharma Acasti Pharma
ACST
 		- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		- - - MOEX russiaRussia
Grifols, S.A. Grifols, S.A.
GRFS
 		$ 7.69 1.39 % $ 6.83 B Nasdaq Global Select Market spainSpain
Avenue Therapeutics Avenue Therapeutics
ATXI
 		- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		- - $ 86.2 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
 		$ 0.6 -2.83 % $ 6.87 M Nasdaq Capital Market israelIsrael
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
Cullinan Management Cullinan Management
CGEM
 		$ 13.01 2.12 % $ 784 M Nasdaq Global Select Market usaUSA
Atreca Atreca
BCEL
 		- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
 		$ 0.8 2.29 % $ 133 M Nasdaq Global Select Market,SPB usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Calithera Biosciences Calithera Biosciences
CALA
 		- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
Incyte Corporation Incyte Corporation
INCY
 		$ 91.13 0.38 % $ 17.8 B Nasdaq Global Select Market,SPB usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		- - $ 169 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
 		- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
 		$ 1.6 0.95 % $ 35.5 M Nasdaq Global Select Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		- - $ 867 M Nasdaq Global Market germanyGermany
Denali Therapeutics Denali Therapeutics
DNLI
 		$ 21.15 4.86 % $ 3.48 B Nasdaq Global Select Market,SPB usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Inventiva S.A. Inventiva S.A.
IVA
 		$ 6.07 5.02 % $ 138 M Nasdaq Global Market franceFrance
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
 		$ 4.3 1.3 % $ 714 M Nasdaq Global Select Market canadaCanada
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
 		- -5.98 % $ 34.1 M Nasdaq Capital Market usaUSA
Decibel Therapeutics Decibel Therapeutics
DBTX
 		- - $ 123 M Nasdaq Global Select Market usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		- - $ 2.18 B Nasdaq Global Select Market,SPB usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
 		$ 1.8 0.08 % $ 120 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.